Contrast-induced nephropathy: searching for new solutions to prevent its development
Journal Title: Нирки - Year 2019, Vol 8, Issue 3
Abstract
Contrast-induced nephropathy (CIN) is the main cause of acute kidney injury and worsens the prognosis of chronic kidney disease. To evaluate the clinical risk score of CIN development, various medical calculators are proposed. The main criterion for assessing the possible development of CIN is the initial glomerular filtration rate presented by estimated glomerular filtration rate. Toxic effect of contrast substances is realized through the properties of the molecule of contrast itself (tubular cell damage) and induced ischemia with oxidative stress and vasoconstriction. Existing methods for preventing the development of CIN are based on reducing the toxic effect of a contrast agent and preventing hypoxic kidney shock. The drugs currently proposed are acetylcysteine, statins, and some other approaches as well as hemodialysis. However, the evidence base is the most informative for hydration, which should be used before the introduction of a contrast agent, along with the minimization of the dose of contrast. Nevertheless, no final solution has been found to prevent the development of CIN. We have proposed the use of edaravone, which has an evidence base for ischemic stroke, to prevent the development of CIN. Three patients with chronic kidney disease stage 3b were given 30 mg edaravone twice a day before contrast media infusion and during two days after contrast administration. In two patients, CIN was avoided. The proposed approach requires future research to evaluate its effectiveness.
Authors and Affiliations
D. D. Ivanov
Keywords
Related Articles
- EP ID EP630037
- DOI 10.22141/2307-1257.8.3.2019.176450
- Views 95
- Downloads 0
Lupus Nephritis: Experience of Treatment with Rituximab (Clinical Observation)
.
Application of Imupret in the Complex Treatment of Chronic Glomerulonephritis in Children
The article presents data on clinical efficacy, tolerability and safety of immunoprophylaxis of acute respiratory viral infections and exacerbation of episodes of acute inflammatory diseases of the upper respiratory trac...
Antibiotic Resistance in Nephrological Practice
The problem of antibiotic resistance is a serious threat to the global public health and requires action by both the state and the public. The World Health Organization identified 15 most dangerous and prevalent superbug...
Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min/1.73 m2) European renal best practice
.
The role of levocarnitine in the systemic therapy of patients of different profile of patients on chronic hemodialysis
the paper presents the pharmacological characteristics of L-carnitine and evaluation of the effectiveness of its application in nephrology practice. Discussed the evidence of the use of levocarnitine for chronic kidney d...